Work

What challenges remain in chronic myeloid leukemia research?

Year: 2013

Type: article

Abstract: In the last fifteen years, the advent of imatinib has opened a new era in the treatment of CML. The challenge now is to eradicate the disease. To do this, groundbreaking scientific and biological studies should lead to the development of new techniques that can eliminate the last leukemic cells.

Source: Haematologica

DOI: 10.3324/haematol.2013.090381

Authors: A. M. Carella, S. Branford, M. Deininger, F. X. Mahon, G. Saglio, A. Eiring, J. Khorashad, T. O'Hare, J. M. Goldman

Institutions: Ospedale Policlinico San Martino, Centre for Cancer Biology, Huntsman Cancer Institute, Centre Hospitalier Universitaire de Bordeaux, University of Turin, University of Utah, Imperial College London

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,157

Funders: Huntsman Cancer Institute, Imperial College London, Università degli Studi di Torino, Directorate for Biological Sciences

OpenAlex ID: W1972056936

FWCI: 1.487

Cites: 52

Cited by: 15

Related to: 10